| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 3,285,000 | 2,506,000 | 2,808,000 | 2,970,000 | | Cost of Revenue | 2,629,000 | 2,119,000 | 2,295,000 | 2,323,000 | | | Gross Profit | 656,000 | 387,000 | 513,000 | 647,000 | | | Operating Expenses | | Research Development | 94,000 | 101,000 | 130,000 | 108,000 | | Selling General and Administrative | 131,000 | 309,000 | 300,000 | 376,000 | | Non Recurring | 35,000 |
-
| (3,000) | 58,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 396,000 | (23,000) | 86,000 | 105,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (209,000) | 56,000 | (22,000) | 198,000 | | Earnings Before Interest And Taxes | 108,000 | 58,000 | 78,000 | 320,000 | | Interest Expense | 45,000 | 56,000 | 57,000 | 93,000 | | Income Before Tax | 63,000 | 2,000 | 21,000 | 227,000 | | Income Tax Expense | 5,000 | 30,000 | 9,000 | (7,000) | | Minority Interest | (18,000) | (7,000) |
-
|
-
| | | | Net Income From Continuing Ops | 109,000 | (35,000) | 12,000 | 234,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items | (23,000) | 23,000 |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 86,000 | (12,000) | 12,000 | 234,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $86,000 | ($12,000) | $12,000 | $234,000 |
|
1.52% Nasdaq 0.00%
Income Statement
